188 related articles for article (PubMed ID: 25297766)
1. [Current status of clinical trials of novel agents for multiple myeloma].
Kuroda J
Rinsho Ketsueki; 2014 Oct; 55(10):2005-15. PubMed ID: 25297766
[No Abstract] [Full Text] [Related]
2. Multiple myeloma--translation of trial results into reality.
Moreau P; Rajkumar SV
Lancet; 2016 Jul; 388(10040):111-3. PubMed ID: 27411865
[No Abstract] [Full Text] [Related]
3. Novel drug combinations for the management of relapsed/refractory multiple myeloma.
Usmani SZ; Lonial S
Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S71-7. PubMed ID: 25486960
[TBL] [Abstract][Full Text] [Related]
4. [Development of novel agents for multiple myeloma; now and the future].
Hata H
Rinsho Ketsueki; 2011 Aug; 52(8):603-8. PubMed ID: 21897065
[No Abstract] [Full Text] [Related]
5. [Present status and perspective of targeted therapy for B-cell lymphoma].
Ohmachi K
Rinsho Ketsueki; 2011 Aug; 52(8):609-17. PubMed ID: 21897066
[No Abstract] [Full Text] [Related]
6. [New drugs in the treatment of multiple myeloma].
Oriol A; Motlló C
Med Clin (Barc); 2014 Sep; 143(6):268-74. PubMed ID: 24342015
[TBL] [Abstract][Full Text] [Related]
7. [Multiple myeloma].
Iida S
Rinsho Ketsueki; 2012 Feb; 53(2):155-63. PubMed ID: 22450574
[No Abstract] [Full Text] [Related]
8. Therapy sequencing strategies in multiple myeloma: who, what and why?
Costello C; Mikhael JR
Future Oncol; 2018 Jan; 14(2):95-99. PubMed ID: 29219615
[No Abstract] [Full Text] [Related]
9. [Molecular targeting agents for multiple myeloma].
Fujii S; Abe M
Nihon Rinsho; 2012 Nov; 70 Suppl 8():518-23. PubMed ID: 23513894
[No Abstract] [Full Text] [Related]
10. The oral histone deacetylase inhibitor LBH589 is a potential and promising therapeutic agent in multiple myeloma after at least two lines of chemotherapy including bortezomib or lenalidomide.
Schmitt S; Ho AD; Goldschmidt H
Onkologie; 2010; 33(4):183-6. PubMed ID: 20389145
[TBL] [Abstract][Full Text] [Related]
11. Current therapeutic strategy for multiple myeloma.
Suzuki K
Jpn J Clin Oncol; 2013 Feb; 43(2):116-24. PubMed ID: 23293370
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of untreated multiple myeloma patients ineligible for autologous stem cell transplantation].
Tsurumi H
Rinsho Ketsueki; 2014 Oct; 55(10):2027-35. PubMed ID: 25297768
[No Abstract] [Full Text] [Related]
13. Safety issues and management of toxicities associated with new treatments for multiple myeloma.
Brioli A; Mügge LO; Hochhaus A; Von Lilienfeld-Toal M
Expert Rev Hematol; 2017 Mar; 10(3):193-205. PubMed ID: 28116920
[TBL] [Abstract][Full Text] [Related]
14. FDA approves new agent for multiple myeloma.
Fenichel MP
J Natl Cancer Inst; 2015 Jun; 107(6):djv165. PubMed ID: 26032612
[No Abstract] [Full Text] [Related]
15. Daratumumab, Elotuzumab, and the Development of Therapeutic Monoclonal Antibodies in Multiple Myeloma.
Laubach JP; Paba Prada CE; Richardson PG; Longo DL
Clin Pharmacol Ther; 2017 Jan; 101(1):81-88. PubMed ID: 27806428
[TBL] [Abstract][Full Text] [Related]
16. Future drug developments in multiple myeloma: an overview of novel lenalidomide-based combination therapies.
Morgan G
Blood Rev; 2010 Nov; 24 Suppl 1():S27-32. PubMed ID: 21126634
[TBL] [Abstract][Full Text] [Related]
17. Perspectives for combination therapy to overcome drug-resistant multiple myeloma.
Catley L; Tai YT; Chauhan D; Anderson KC
Drug Resist Updat; 2005 Aug; 8(4):205-18. PubMed ID: 16019253
[TBL] [Abstract][Full Text] [Related]
18. Elotuzumab in multiple myeloma.
Burki TK
Lancet Oncol; 2018 Dec; 19(12):e675. PubMed ID: 30449660
[No Abstract] [Full Text] [Related]
19. Emerging biological insights and novel treatment strategies in multiple myeloma.
Gentile M; Recchia AG; Mazzone C; Morabito F
Expert Opin Emerg Drugs; 2012 Sep; 17(3):407-38. PubMed ID: 22920042
[TBL] [Abstract][Full Text] [Related]
20. Lenalidomide in multiple myeloma: current role and future directions.
Zeldis JB; Knight RD; Jacques C; Tozer A; Bizzari JP
Expert Opin Pharmacother; 2010 Apr; 11(5):829-42. PubMed ID: 20210686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
